FDA Seeks Input on Regulatory Framework for GenAI Medical Devices

The FDA has released a discussion paper seeking public input on a proposed regulatory framework specifically for generative AI medical devices, focusing on risk assessment, premarket evaluation, and postmarket monitoring. This is the agency's first formal attempt to create specific regulation for GenAI in healthcare, with comments due by October 19, 2026.

This Wire brief sits within Fusion42's coverage of Medtech, and 13 sources have reported it between 18 Aug 2026 and 19 Aug 2026.